R. Session
Director/Board Member at Lung Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sean Nolan | M | 56 | 8 years | |
| Sukumar Nagendran | M | 58 | 8 years | |
| Fariborz Kamal | M | 61 | 7 years | |
| Philip Donenberg | M | 63 | 7 years | |
| David J. Lockhart | M | 62 |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | - |
| Brian H. Dovey | M | 83 |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Laura Sepp-Lorenzino | M | 63 | 4 years | |
| Robert Mills | M | 71 |
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | 9 years |
| Eric Aguiar | M | 62 | 5 years | |
| Shehnaaz Suliman | M | 52 |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | 2 years |
| Kamran Alam | M | 46 | 4 years | |
| Martin Rexroad | M | - | 11 years | |
| Ronald Daniels | M | 64 | 4 years | |
| Glenn Steele | M | 79 | 9 years | |
| Steven Idell | M | - |
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | 12 years |
| Jenny Lee | F | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 8 years |
| Jeffrey Weinstein | M | 35 |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 5 years |
| Matthew Outten | M | 49 | 5 years | |
| Aaron Fletcher | M | 44 |
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | 10 years |
| Brad Feld | M | 58 |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 8 years |
| Mira Chaurushiya | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Renato Fairbanks de Sá e Silva Ribeiro | M | 44 |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Stephen Curtis | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 9 years |
| Rana Al-Hallaq | M | - |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | - |
| Tracy M. Porter | F | - | 3 years | |
| Emily McGinnis | F | - | 4 years | |
| Rakhshita Dhar | F | - |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | 2 years |
| Sean McAuliffe | M | - | 4 years | |
| Murad Husain | M | - | 10 years | |
| Mary Newman | F | 65 | 3 years | |
| Fernando Fabre | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Peter Thompson | M | 64 |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | - |
| Alan Colowick | M | 61 |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | 2 years |
| Eric Pauwels | M | 63 | 9 years | |
| Tom Baruch | M | 85 |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Edward Hurwitz | M | 60 |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | - |
| Jason Green | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Helen Kim | F | 61 |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | 4 years |
| Sanuj K. Ravindran | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Josh Stein | M | 50 |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Vikas Goyal | M | 45 |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Domenico Nesci | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 10 years |
| Oleg Nodelman | M | 47 |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | - |
| Christine Siu | F | 47 | 4 years | |
| Mamoon Hamid | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 8 years |
| Nelson K. Stacks | M | 53 |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | - |
| Jennifer Cook | F | 58 | 5 years | |
| Thad Langford | M | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 7 years |
| Rusty Dornin | F | - |
Society of Kauffman Fellows
Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | 11 years |
| Trisha Millican | F | - |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Manning | M | 68 | 8 years | |
| Marcio Souza | M | 45 | 6 years | |
| Kim Lee | M | - | - | |
| Richard H. Aldrich | M | 69 | 2 years | |
| Cláudia Hirawat | F | 53 | 15 years | |
| Kathleen Reape | M | 58 | 3 years | |
| Claire Aldridge | M | - | 1 years | |
| Megan Sniecinski | F | 43 | 5 years | |
| Lisa Deschamps | F | 52 | 3 years | |
| Jonathan Leff | M | 55 | 3 years | |
| Peter Francis | M | 55 | 6 years | |
| Kurt J. W. Andrews | M | 54 | 9 years | |
| Timothy J. Douros | M | - | - | |
| Bong Koh | M | - | - | |
| Dawn Svoronos | F | 70 | 6 years | |
| Emily Hill | F | 44 | - | |
| Axel Bolte | M | 52 | 11 years | |
| Carole Nüchterlein | F | 62 | 3 years | |
| Daniel Welch | M | 66 | 2 years | |
| Tony Yao | M | 51 | - | |
| Ronald Renaud | M | 55 | 3 years | |
| Terrence Kearney | M | 69 | 2 years | |
| Michael L. Kranda | M | 69 | 12 years | |
| Frank Verwiel | M | 62 | 3 years | |
| Stephen Bardin | M | 34 | 3 years | |
| Joseph Nolan | M | 61 | - | |
| Ching Yau Yi | F | - | 3 years | |
| Sean Gaskell | M | 42 | 2 years | |
| Robert May | M | 56 | 2 years | |
| Petra Kaufmann | M | 58 | 2 years | |
| Ritu Shah | F | 48 | 1 years | |
| Morgan Conn | M | 42 | 16 years | |
| Ross Moat | M | 43 | 1 years | |
| Adrian Haigh | M | 64 | 8 years | |
| Berge Minassian | M | - | - | |
| Steven Gray | M | - | - | |
| Scott Wilhoit | M | 61 | 1 years | |
| Eli M. Wallace | M | 57 | - | |
| William Hornung | M | 55 | 12 years | |
| Jay Barth | M | 60 | 5 years | |
| Edward O'Mara | M | - | 4 years | |
| Alan Musso | M | 62 |
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | - |
| Craig Osten | M | - | - | |
| Robert Spiegel | M | 73 | 5 years | |
| William Fairey | M | 60 |
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | 2 years |
| Brian Stolz | M | 48 | 1 years | |
| Alyssa Wyant | F | 49 | 2 years | |
| Suyash Prasad | M | 54 | 3 years | |
| Shane Kovacs | M | 50 | - | |
| Stephen J. Moloney | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- R. Session
- Personal Network